ArticleInternational journal of clinical pharmacy2026

Cost-effectiveness of omadacycline versus moxifloxacin as the initial treatment for community-acquired bacterial pneumonia in China.

Xiuling Wang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.